Catherine Passirani
AuthID: R-00J-M1B
1
TITLE: Special Issue: New Diagnostic and Therapeutic Tools against Multidrug-Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104) Full Text
AUTHORS: Vasconcelos, M. Helena ; Passirani, Catherine; Riganti, Chiara;
PUBLISHED: 2022, SOURCE: CANCERS, VOLUME: 14, ISSUE: 22
AUTHORS: Vasconcelos, M. Helena ; Passirani, Catherine; Riganti, Chiara;
PUBLISHED: 2022, SOURCE: CANCERS, VOLUME: 14, ISSUE: 22
2
TITLE: Modulating undruggable targets to overcome cancer therapy resistance Full Text
AUTHORS: Catherine Passirani; Anne Vessières; Giuseppe La Regina; Wolfgang Link ; Romano Silvestri;
PUBLISHED: 2022, SOURCE: Drug Resistance Updates, VOLUME: 60
AUTHORS: Catherine Passirani; Anne Vessières; Giuseppe La Regina; Wolfgang Link ; Romano Silvestri;
PUBLISHED: 2022, SOURCE: Drug Resistance Updates, VOLUME: 60
3
TITLE: Nanomedicine to target multidrug resistant tumors Full Text
AUTHORS: Elise Lepeltier; Patricia Rijo ; Flavio Rizzolio; Rachela Popovtzer; Vilma Petrikaite; Yehuda G Assaraf; Catherine Passirani;
PUBLISHED: 2020, SOURCE: DRUG RESISTANCE UPDATES, VOLUME: 52
AUTHORS: Elise Lepeltier; Patricia Rijo ; Flavio Rizzolio; Rachela Popovtzer; Vilma Petrikaite; Yehuda G Assaraf; Catherine Passirani;
PUBLISHED: 2020, SOURCE: DRUG RESISTANCE UPDATES, VOLUME: 52
